Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

173
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
173
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

525
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
525
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

247
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
247
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

334
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
334
Cancer Survival Analysis01:21

Cancer Survival Analysis

413
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
413
Survival Tree01:19

Survival Tree

132
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
132

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual- and Cluster-Randomized Trials.

Statistics in medicine·2026
Same author

Robust Heterogeneity Adjustment for Gaussian Graphical Model With Latent Variables.

Statistics in medicine·2026
Same author

DNN-based semiparametric AFT model for integrating genomic and pathological imaging data in cancer prognosis.

Biometrics·2026
Same author

Integrating Omics and Pathological Imaging Data for Cancer Prognosis via a Deep Neural Network-Based Cox Model.

Statistics in medicine·2026
Same author

Structured Nonlinear Cure Model With Deep Neural Networks for High-Dimensional Survival Analysis.

Statistics in medicine·2026
Same author

Analysis of cross-platform health communication with a network approach.

Biometrics·2025
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Aug 17, 2025

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.3K

Two-level Bayesian interaction analysis for survival data incorporating pathway information.

Xing Qin1, Shuangge Ma2, Mengyun Wu1

  • 1School of Statistics and Management, Shanghai University of Finance and Economics, Shanghai, China.

Biometrics
|December 16, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a new Bayesian method to analyze gene and pathway interactions in complex diseases, improving survival prediction by examining gene-gene and pathway-pathway effects simultaneously.

Keywords:
Bayesian analysisinteraction analysissurvival datatwo-level selection

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.5K

Related Experiment Videos

Last Updated: Aug 17, 2025

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.3K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.5K

Area of Science:

  • Genetics
  • Bioinformatics
  • Biostatistics

Background:

  • Genetic interactions influence complex disease progression and phenotype variations not explained by main genetic effects.
  • Survival analysis for complex diseases is challenging due to data characteristics like censoring.
  • Two-level analysis of genes and pathways is effective, but existing methods often miss pathway interactions.

Purpose of the Study:

  • To develop a novel two-level Bayesian interaction analysis approach for survival data.
  • To simultaneously analyze gene-gene and pathway-pathway interactions.
  • To improve the understanding of genetic contributions to complex disease prognosis.

Main Methods:

  • A novel two-level Bayesian interaction analysis framework using variational inference.
  • Application of the accelerated failure time model with effective priors.
  • Accommodating two-level selection and data censoring in high-dimensional settings.

Main Results:

  • The proposed approach effectively analyzes both gene-gene and pathway-pathway interactions simultaneously.
  • The variational inference framework offers computational efficiency for high-dimensional data.
  • Application to TCGA melanoma and lung adenocarcinoma data yielded biologically relevant findings.

Conclusions:

  • The developed method provides a powerful tool for analyzing complex genetic interactions in survival data.
  • This approach enhances prediction accuracy and selection stability in disease prognosis.
  • It represents a significant advancement in multi-level genetic interaction analysis for complex diseases.